The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Comparative pharmacology of chemically distinct NADPH oxidase inhibitors
Open accessAbstract
BACKGROUND AND PURPOSE Oxidative stress [i.e. increased levels of reactive oxygen species (ROS)] has been suggested as a pathomechanism of different diseases, although the disease‐relevant sources of ROS remain to be identified. One of these sources may be NADPH oxidases. However, due to increasing concerns about the specificity of the compounds commonly used as NADPH oxidase inhibitors, data obtained with these compounds may have to be re‐interpreted. EXPERIMENTAL APPROACH We compared the pharmacological profiles of the commonly used NADPH oxidase inhibitors, diphenylene iodonium (DPI), apocynin and 4‐(2‐amino‐ethyl)‐benzolsulphonyl‐fluoride (AEBSF), as well as the novel triazolo pyrimidine VAS3947. We used several assays for detecting cellular and tissue ROS, as none of them is specific and artefact free. KEY RESULTS DPI abolished NADPH oxidase‐mediated ROS formation, but also inhibited other flavo‐enzymes such as NO synthase (NOS) and xanthine oxidase (XOD). Apocynin interfered with ROS detection and varied considerably in efficacy and potency, as did AEBSF. Conversely, the novel NADPH oxidase inhibitor, VAS3947, consistently inhibited NADPH oxidase activity in low micromolar concentrations, and interfered neither with ROS detection nor with XOD or eNOS activities. VAS3947 attenuated ROS formation in aortas of spontaneously hypertensive rats (SHRs), where NOS or XOD inhibitors were without effect. CONCLUSIONS AND IMPLICATIONS Our data suggest that triazolo pyrimidines such as VAS3947 are specific NADPH oxidase inhibitors, while DPI and apocynin can no longer be recommended. Based on the effects of VAS3947, NADPH oxidases appear to be a major source of ROS in aortas of SHRs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This includes Nox enzymes but also, for example, complex I of the ETC [63,250,251], iNOS [400,401] and XO [394,399] as well as calcium transporters [402].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [394]
In the citing paper
“However, due to its chemistry, it unselectively inhibits all flavin-containing enzymes of the cell [393,394,399].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [394]
In the citing paper
“VAS2870 was the first published inhibitor that resulted from a systematic screening effort for selective NADPH oxidase inhibitors by Tegtmeier and colleagues [394].”
From Functions of ROS in Macrophages and Antimicrobial Immunity (2021) · cites this paper as [394]
In the citing paper
“Thus, ROS originating from NOX4 activation may be important in activating microglia in response to neuronal damage via stimulation of p38 MAPK and JNK.”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [157]
In the citing paper
“Whilst the ROS generated here are believed to originate from NOX4 expression, the specificity of apocynin for NOX4 has been questioned [157].”
From ROS Generation in Microglia: Understanding Oxidative Stress and Inflammation in Neurodegenerative Disease (2020) · cites this paper as [157]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,651
A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish
Niethammer, P., Grabher, C., Look, A. T., & Mitchison, T. J. (2009) · Nature · doi:10.1038/nature08119 · Cited by 1,541
Cell transformation by the superoxide-generating oxidase Mox1
Suh, Y.-A., Arnold, R. S., Lassegue, B., Shi, J., Xu, X., Sorescu, D., Chung, A. B., Griendling, K. K., & Lambeth, J. D. (1999) · Nature · doi:10.1038/43459 · Cited by 1,480
Vascular NAD(P)H oxidases: specific features, expression, and regulation
Lassegue, B. P., & Clempus, R. E. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00758.2002 · Cited by 1,026
BABIOR, B. M., Lambeth, J. D., & Nauseef, W. M. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2642 · Cited by 911
Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an Antioxidant
Heumüller, S., Wind, S., Barbosa-Sicard, E., Schmidt, H. H. H. W., Busse, R., Schröder, K., & Brandes, R. P. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.100214 · Cited by 735
Self-citationKobayashi, M., Ohura, I., Kawakita, K., Yokota, N., Fujiwara, M., Shimamoto, K., Doke, N., & Yoshioka, H. (2007) · The Plant Cell · doi:10.1105/tpc.106.048884 · Cited by 694
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Cited by
Sorted by citations
Items 201–241 of 241
Diagnosis and individual treatment of cardiovascular diseases: targeting vascular oxidative stress
Armitage, M. E., La, M., Schmidt, H. H. H. W., & Wingler, K. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.40 · Cited by 6
Self-citationPeripheral Artery Disease in Diabetes Mellitus: Focus on Novel Treatment Options
Demarchi, A., Somaschini, A., Cornara, S., & Androulakis, E. S. (2020) · Current Pharmaceutical Design · doi:10.2174/1389201021666201126143217 · Cited by 7
Isoform-Selective Nox Inhibitors: Advances and Future Perspectives
Dustin, C. M., Cifuentes-Pagano, E., & Pagano, P. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-23752-2_21 · Cited by 5
NAD(P)H oxidase isoforms as therapeutic targets for diabetic complications
Gray, S. P., Jha, J. C., Marco, E. D., & Jandeleit-Dahm, K. A. M. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2014.887984 · Cited by 5
Oxidative Stress and Carcinogenesis
Bansal, M., & Kaushal, N. (2014) · Springer eBooks · doi:10.1007/978-81-322-2032-9_4 · Cited by 5
Isoform-selective NADPH oxidase inhibitor panel for pharmacological target validationPreprint
Dao, V. T.-V., Elbatreek, M. H., Altenhöfer, S., Casas, A. I., Pachado, M. P., Neullens, C. T., Knaus, U., & Schmidt, H. H. H. W. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/382226 · Cited by 5
Self-citationPandey, A. R., Ansari, W. A., Maurya, P., Aslam, H., Pandey, R. R., Mishra, D. P., Rab, S. O., Ahmad, S., Puri, P., & Khan, M. F. (2025) · ChemistrySelect · doi:10.1002/slct.202500637 · Cited by 5
Role of NADPH Oxidase in Beta Cell Dysfunction
Weaver, J. R., & Taylor, D. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_46-3 · Cited by 4
Eaton, L., Welch, I., Halal, A. K., Bengtsson, J., & Pamenter, M. E. (2022) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2022.111342 · Cited by 4
Endothelial HO-1 induction by model TG-rich lipoproteins is regulated through a NOX4-Nrf2 pathway
Latham, S. H., Purcell, R. H., Botham, K. M., & Wheeler-Jones, C. P. D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m067108 · Cited by 4
Абатуров, А. Е., Волосовец, А. П., & Borysovа, T. P. (2018) · CHILD`S HEALTH · doi:10.22141/2224-0551.13.2.2018.129558 · Cited by 4
Guedira, G., Petermann, O., Scapozza, L., & Ismail, H. M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116957 · Cited by 3
[Research progress of NADPH oxidases and their inhibitors].
Yang, X.-L., Chen, Y.-J., Hu, G., & Li, Q. (2016) · PubMed · Cited by 3
Germon, Z. P., Sillar, J. R., Mannan, A., Duchatel, R. J., Staudt, D. E., Murray, H. C., Findlay, I. J., Jackson, E. R., McEwen, H. P., Douglas, A. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.09.483687 · Cited by 3
Beinart, F. R., & Gillen, K. M. (2025) · Development Growth & Differentiation · doi:10.1111/dgd.12961 · Cited by 2
Heleven, M., Molina, M. D., Jaenen, V., Bijnens, K., Cebrià, F., & Smeets, K. (2026) · iScience · doi:10.1016/j.isci.2026.115640 · Cited by 2
Role of NADPH Oxidase in β Cell Dysfunction
Weaver, J. R., & Taylor, D. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_46 · Cited by 2
Inhibiting NOXO1 and CYBA binding to reduce NADPH oxidase I dependent ROS damage in skin explants
Senevirathne, P. P., Sterling, A., Refaei, M. A., Mokhtarpour, N., Gutierrez-Rivera, L., Garcia, J., Dragovic, M., Premnauth, G., Tsang, P., Kadekaro, A. L., et al. (2023) · Results in Chemistry · doi:10.1016/j.rechem.2023.101213 · Cited by 2
Oxidative Stress and Nitric Oxide in Cerebral Ischemic Reperfusion Injury
Ma, J., Liu, Z., & Shi, Z. (2018) · Springer series in translational stroke research · doi:10.1007/978-3-319-90194-7_7 · Cited by 2
New Therapeutics in Hypertension
Alvarez, J. L. L. (2012) · InTech eBooks · doi:10.5772/36050 · Cited by 1
Rezende, F., Löwe, O., Helfinger, V., Prior, K.-K., Walter, M., Zukunft, S., Fleming, I., Weißmann, N., Brandes, R. P., & Schröder, K. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6396 · Cited by 1
Maity, S., Padhy, G. K., Kanthal, L. K., & Pattanayak, S. (2023) · Asian Journal of Chemistry · doi:10.14233/ajchem.2024.28337 · Cited by 1
Sources of Reactive Oxygen Species in Normoxic and Hypoxic Naked Mole-Rat Brain
Eaton, L., Bengtsson, J., Welch, I., Halal, A. K., & Pamenter, M. E. (2024) · Medical Research Archives · doi:10.18103/mra.v12i1.4857 · Cited by 1
Neutrophil Cellular Responses to Various Salmonella typhimurium LPS Chemotypes
Anna, N., Svetlana, I., Zoryana, V., Galina, M., Julia, M., Michail, I., Steinhilber, D., & Sud’ina, G. F. (2012) · InTech eBooks · doi:10.5772/29087 · Cited by 1
Role of NADPH Oxidase in b Cell Dysfunction 34
Weaver, J. R., & Taylor, D. (2015)
Studies of polyglutamine expanded Ataxin-7 toxicity
Yu, X. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Zhou, Z. (2016) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27581778
regulation by EGF, insulin, and IGF-1 ROS production as a common mechanism of ENaC
Ilatovskaya, D. V., Pavlov, T. S., & Levchenko, V. (2016)
Sinalização redox na diferenciação osteogênica
Simões, V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.41.2016.tde-29082016-105249
Reply to the letter regarding NADPH oxidase inhibitor
Iida, H., Kito, K., & Tanabe, K. (2018) · Journal of Anesthesia · doi:10.1007/s00540-018-2553-1
Oxygen homeostasis and stress in the ductus arteriosus
van der Sterren, S. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160309ss
Moulahoum, H., Ghorbanizamani, F., Tımur, S., & Zihnioğlu, F. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_43-1
Moulahoum, H., Ghorbanizamani, F., Tımur, S., & Zihnioğlu, F. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_43
Activité NADPH oxydase des cellules de leucémie aiguë myéloïde
Leclerc, J. (2013) · theses.fr (ABES) · doi:10.70675/5743e778zd4fdz4faazbccfz81db73478c61
Caractérisation des NADPH oxydases et effet de leur inhibition dans les leucémies aigues myéloïdes
Dakik, H. (2017) · theses.fr (ABES) · doi:10.70675/c50123fez19eaz4414zaf63z4c616441a1d3
Caillot, M. (2022) · theses.fr (ABES) · doi:10.70675/69fdc951z6d60z453bzbc0bz632f2f850876
Shih, Y., Hsu, C.-C., Hsu, C.-H., Kuo, P.-Y., Wang, Y.-H., Lee, W.-H., & Jung, C. (2026) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiag343
Echeverría‐Rodríguez, O., Rodríguez, S. R., Torres, S. D. H., Riveros‐Rosas, H., Ortiz, I. A. G., Molina, R. V., & Vilchis‐Landeros, M. M. (2026) · Vascular Pharmacology · doi:10.1016/j.vph.2026.107692
BindingDB Entry 50020295: NADPH Oxidases: From Molecular Mechanisms to Current Inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q2jm2g3p
BindingDB (2020) · UC San Diego · doi:10.7270/q2j38wjk
Metadata
- Authors
- Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K.
- Affiliations
- Justus-Liebig-Universität Gießen (DE)
- Vasopharm (Germany) (DE)
- Florey Institute of Neuroscience and Mental Health (AU)
- ORCID
- Wind, S
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2010-06-17
- Volume
- 161
- Issue
- 4
- Pages
- 885-898
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC2970907
- OpenAlex
- W1736337862
- Cited by
- 241
- References
- 50
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 16 · 2016: 23 · 2015: 23 · 2014: 28 · 2013: 29 · 2012: 31
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB-547)
- Bayerische Forschungsstiftung
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- NADPH oxidase inhibitors, reactive oxygen species, oxidative stress, diphenyleneiodonium, apocynin, AEBSF, xanthine oxidase inhibition, eNOS inhibition, spontaneously hypertensive rats, aorta
- MeSH terms
- Acetophenones, Animals, Aorta, Cell Line, Enzyme Inhibitors, Humans, Onium Compounds, Pyrimidines, Rats, Inbred SHR, Rats, Inbred WKY, Sulfones, Triazoles, Reactive Oxygen Species, Oxidative Stress, HL-60 Cells, Caco-2 Cells, NADPH Oxidases, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
